Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the Company or Appili), a biopharmaceutical company developing anti-infective drug candidates, today announced that its common shares will commence trading on the Toronto Stock Exchange (TSX) as of the opening of trading on Wednesday, September 16, 2020, under the Company's current trading symbol, "APLI."

Read the new release.

Appili Therapeutics is an Innovacorp portfolio company.

Halifax, Nova Scotia, September 14, 2020